Sujin Kim

3.1k citations
72 papers · 2.3k indexed · 1 hit paper · h-index 24

Sujin Kim

70 papers receiving 2.2k citations

Hit Papers

Second-generation anti-amyloid monoclonal antibodies for ...3920252026102030

Peers

Sujin Kim
Comparison fields: 5 of 134
  • Biological Psychiatry 105
  • Periodontics 174
  • Physiology 497
  • Molecular Biology 1.3k
  • Pharmacology 104
Replace Jaewang Ghim with:
Jaewang Ghim South Korea
Mariana Lima Vale Brazil
Nima Sanadgol Iran
Elizabeth S. Fernandes Brazil
Luis A. Salazar Chile
Małgorzata Żendzian‐Piotrowska Poland
Liping Liang China
Francesca Pistollato Italy
Domenico Nuzzo Italy
Sujin Kim relative to Jaewang Ghim South Korea Jaewang Ghim's profile →
Citations per field
00.5×3.8×
Jaewang Ghim · 1×
Citations per year

Countries citing papers authored by Sujin Kim

Since Specialization
Citations

This map shows the geographic impact of Sujin Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sujin Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sujin Kim more than expected).

Fields of papers citing papers by Sujin Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sujin Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sujin Kim. The network helps show where Sujin Kim may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sujin Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sujin Kim Line = papers co-authored together Sujin Kim links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202412
2 20241
3 202417
4 20245
5 20244
6 20240
7 20239
8 20229
9 20224
10 201919
11 201939
12 20189
13 201610
14 201528
15 201315
16 2013246
17 201324
18 201114
19 200417
20
Convenient Evaluation of Stored Apple Pollen Viability by Fluorochromatic Reaction
19991

About Sujin Kim

Sujin Kim is a scholar working on Biological Psychiatry, Pharmacology and Physiology, having authored 72 papers that have together received 2.3k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (12 papers), RNA regulation and disease (8 papers), interferon and immune responses (7 papers), Pharmacological Effects of Natural Compounds (7 papers), RNA modifications and cancer (7 papers), Natural product bioactivities and synthesis (7 papers), Ginseng Biological Effects and Applications (5 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Biological Psychiatry (105 citations), Periodontics (174 citations) and Physiology (497 citations). Sujin Kim has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Wataru Suda, Kenshiro Oshima, Masahira Hattori, Hidetoshi Morita, Yoosik Kim, Minho Moon, Christopher H.S. McIntosh, Makoto Tsuneoka, Cuilan Nian and Yoshiro Koda. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026